TriSalus Life Sciences (TLSI) Return on Sales (2022 - 2026)

TriSalus Life Sciences' Return on Sales history runs 5 years deep, the most recent figure standing at 0.0% for Q1 2026.

• On a quarterly basis, Return on Sales rose 1.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.01%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.01%, changed 0.0% from the prior year.
• Return on Sales rose to 0.0% in Q1 2026 per TLSI's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q1 2026 and bottomed at 0.07% in Q4 2022.
• The 5-year median for Return on Sales is 0.01% (2025), against an average of 0.02%.
• Across the five-year window, Return on Sales rose 5 bps in 2024 and declined 1 bps in 2025, its largest moves.
• Year by year, Return on Sales stood at 0.07% in 2022, then advanced by 11 bps to 0.06% in 2023, then soared by 80 bps to 0.01% in 2024, then jumped by 40 bps to 0.01% in 2025, then jumped by 123 bps to 0.0% in 2026.
• Per Business Quant, the three latest TLSI Return on Sales figures stand at 0.0% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).